prognostic value of plasma biomarkers gfap and ptau181 for all-cause and alzheimer’s dementia
Published 3 months ago • 41 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
2:11
upcoming plasma biomarkers for alzheimer’s disease: aβ, p-tau and gfap
-
1:58
the value of plasma p-tau181 as a screening and diagnostic tool for alzheimer’s disease
-
4:22
prognostic accuracy of plasma nfl to predict alzheimer’s disease dementia
-
1:36
using plasma biomarkers in the diagnosis of alzheimer’s disease
-
3:19
prognostic blood biomarkers in the pre-clinical stages of alzheimer’s disease
-
2:57
the potential of plasma biomarkers in dementia
-
4:07
plasma versus neuroimaging biomarkers for alzheimer’s disease clinical trials
-
2:47
latest knowledge on plasma p-tau in alzheimer’s disease
-
2:25
plasma biomarkers for population-based alzheimer’s disease screening
-
1:45
the accuracy of plasma biomarkers for alzheimer’s disease outside of a controlled setting
-
1:12
beyond aβ and p-tau: novel biomarkers under investigation for alzheimer’s disease
-
1:32
investigating novel plasma-based p-tau biomarkers
-
1:23
plasma biomarkers for alzheimer's disease as pre-screening tools
-
9:39
plasma amyloid, gfap, nf-l and ptau as predictors of alzheimer's pathology
-
1:02
the need for improved prognostic markers in alzheimer’s disease
-
1:33
which plasma biomarkers hold the most promise in alzheimer’s disease?
-
3:41
diagnostic performance of gfap in csf, plasma, and serum with age
-
3:42
biomarker blood tests as diagnostic tool for alzheimer's disease
-
2:19
early predictive value of plasma biomarkers for amyloid positivity